Concepedia

Jinqi Liu

JL

24

Publications

1.6K

Citations

19

H-Index

1997

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Bristol-Myers Squibb (United States)

Eli Lilly (United States)

The University of Texas at Austin

Shanghai Institute of Materia Medica

Jinqi Liu is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cell signaling, and pharmacology.

Top concepts

MedicinePharmacologyCell SignalingBiochemistryCell BiologyImmunologyPhysiologyMetabolismHealthCell Death

Publications per year

1997–2023

24

Publications

24

Targeting a ceramide double bond improves insulin resistance and hepatic steatosis

Bhagirath Chaurasia, Trevor S. Tippetts, Rafael Mayoral et al. · Science · 2019 · 432 citations · Full text

Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy

Robert W. Myers, Hong-Ping Guan, Juliann Ehrhart et al. · Science · 2017 · 329 citations

Cardiac Muscle, Cardiovascular Pharmacology, Glucose Homeostasis +23

The Matrix Attachment Region-Binding Protein SATB1 Participates in Negative Regulation of Tissue-Specific Gene Expression

Jinqi Liu, Debra E. Bramblett, Quan Zhu et al. · Molecular and Cellular Biology · 1997 · 116 citations · Full text

Pathology, Tumor Biology, Cancer-associated Virus +19

Enhanced CD4+ T Cell Proliferation and Th2 Cytokine Production in DR6-Deficient Mice

Jinqi Liu, Songqing Na, Andrew L. Glasebrook et al. · Immunity · 2001 · 83 citations · Full text

Inflammation, Autoimmune Disease, Lymphocyte Development +10

Enhanced antitumor immunity by a novel small molecule HPK1 inhibitor

Dan You, Stephen Hillerman, Gregory Locke et al. · Journal for ImmunoTherapy of Cancer · 2021 · 75 citations · Full text

Rows per page

1–5 of 24